Skip to main content
. 2016 Nov 18;11(11):e0166750. doi: 10.1371/journal.pone.0166750

Table 1. Effects of MDMA, clorgyline, deprenyl, fluoxetine and the combinations on MTT reduction in P19 neurons.

Compounds 24 hours of incubation 48 hours of incubation
37°C 40°C 42°C 37°C 40°C 42°C
Controls 98±2.7 95±3.1 104±2.5 100±2.8 97±5.6 105±4.6
0.1% DMSO 103±2.5 100±7.9 104±7.7 112±3.4 107±6.5 105±3.0
0.3 mM MDMA 90±9.0 86±5.0 71±4.3*** 93±6.2 86±6.4 73±8.3*
1 mM MDMA 66±4.6** 61±4.4** 33±6.1**** 51±1.4**** 67±3.7* 42±13***
1 μM Clorg. 95±8.0 90±7.0 104±3.3 108±3.7 101±7.1 105±8.1
1 μM Depr. 110±3.6 103±6.2 112±5.6 112±7.9 113±3.8 113±6.2
1 μM Clorg.+ 1 μM Depr. 103±7.5 104±8.9 106±4.3 103±5.9 101±12 112±4.3
10 nM Fluox. 100±10 99±14 83±16 91±11 108±4.1 102±13
100 nM Fluox. 92±13 94±9.9 73±16 87±9.7 94±10 85±11
1 μM Fluox. 106±7.2 101±11 82±9.7 91±1.8 105±5.3 91±9.7
1 μM Clorg. + 1 μM Depr. + 1 μM Fluox. 96±7.7 94±9.1 76±6.9 82±8.8 86±5.4 98±13

The compounds were added to the cells on day 7 in the serum-free medium followed by 24 h and 48 h incubation at 37°C, 40°C and 42°C, in a humified atmosphere with 5% CO2. Data (means ± SEM of four independent experiments) are expressed as percent of untreated controls or DMSO vehicle for fluoxetine. Statistical analysis was performed using one-way ANOVA with post hoc Dunnett’s multiple comparisons test against untreated controls or DMSO for fluoxetine (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001).